We found that 7% of all tested samples were substandard and 3.6% were likely counterfeit. Frankly that seems low to me, almost reassuring. Not that I'll specify Indian drugs just yet, though. I'm probably just expressing a cultural bias.
Market Data 
Markets
AI
